Medicare Part D’s 2024 redesign—catastrophic coinsurance removal and expanded full LIS eligibility—was associated with a ...
LOS ANGELES — The median cost of brand-name anti-seizure medications (ASMs) in the United States almost doubled from 2013 to 2023, whereas generic ASM prices declined over the same period, results of ...
Medicare beneficiaries with heart disease or major cardiovascular risk factors reported less cost-related medication ...
The National Institute for Occupational Safety and Health (NIOSH) has published the 2024 update to its List of Hazardous Drugs in Healthcare Settings, marking the first revision since 2016. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results